IntelGenx announces results from POC study of VetaFilm platform

IntelGenx announced positive results from a proof-of-concept, POC, study to assess the palatability, owner-perceived acceptability, and ease of repeated administration of IntelGenx’s VetaFilm platform in healthy dogs and cats. The POC study was conducted through a research collaboration with the University Prince Edward Island, one of North America’s leading veterinary universities. Key findings included: The VetaFilm FDOFs were well accepted and well tolerated by both dogs and cats; Repeated dosing showed high continued acceptance rates in both species with little or no effect of time on the continued acceptance of the VetaFilm FDOFs; Overall, 100% of dog owners and 67% of cat owners felt that administration of the VetaFilm FDOFs was “very easy” or “easy”; and 95% of dog owners and 82% of cat owners identified VetaFilm FDOFs as the preferred method of medication administration.